Company Background & History
Set-up of PCR group at GRC
The German Red Cross in Frankfurt establishes a dedicated PCR group to develop PCR tests for blood screening.
First PCR test in routine
The GRC introduces the first PCR test for routine NAT screening of HCV.
1997 – 2004
Various new PCR tests
In a short sequence the GRC develops and introduces various in-house PCR assays for the routine blood screening.
Foundation of GFE
Three GRC organisations establish the GFE to bring NAT testing to the full IVD level. Prof. Dr. med. W. Kurt Roth appointed as CEO.
Certification of company and products
ISO 13485, ISO 9001 and IVD-Guideline 98/79/EG certification
Launch of autoX-System
GFE introduces the autoX-System for the routine NAT blood screening.
New production site
The GFE establishes the kit production on a new production site in Frankfurt Griesheim.
Registration of manual assays
GFE registers the confirmatory kits for the manual use with third party extraction.
Triple target HIV-1 test
GFE introduces the proprietary HIV-1 triple target test to increase blood safety.
Release of new WNV PCR Kit
GFE redesigned its WNV PCR Kit and releases the new version into the market.
First preview of PoET
A fist preview of the new PoET-Instrument design study shown at the ISBT in Dubai.
Dr. Reiner Babiel appointed new CEO
Change of general managment after retirement of Prof. Dr. med. W. Kurt Roth.